1. Home
  2. Analysis
  3. Acacia

Acacia: effectiveness, side effects, alternatives

Summary:

Acacia: acacia

We study 40 Acacia users. The information eHealthMe analyzes includes:

- Effectiveness of Acacia
- Alternative drugs to Acacia
- 97 Acacia side effects and drug interactions

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

Number of reports submitted per year:

Acacia: 40 reports from FDA and social media.

Common Acacia side effects:

Acacia side effects by duration, gender and age:

Browse all side effects of Acacia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acacia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Do you take Acacia?

- You can start a phase IV clinical trial to monitor Acacia safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all drugs on eHealthMe.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.